SCHEMBL4557299

SCHEMBL4557299

CCc1cc(OC)ccc1-c1ccc(C(C)=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 1/20 0.50
HSD17B1 P14061 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
CYP1A2 P05177 2/20 0.48
KDM4E B2RXH2 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
SYK P43405 4/20 0.47
KMT2A Q03164 2/20 0.47
BACE1 P56817 1/20 0.45
BAZ2B Q9UIF8 1/20 0.45
BAZ2A Q9UIF9 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45
AURKB Q96GD4 2/20 0.44
INCENP Q9NQS7 2/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4557296 0.91 SYK (0.53) SRD5A2HSD17B1SMN1; SMN2CYP1A2KDM4E
SCHEMBL2997363 0.88 SRD5A2 (0.63) SRD5A2SMN1; SMN2CYP1A2KDM4ECYP2D6
SCHEMBL2997357 0.82 SMN1; SMN2 (0.56) SRD5A2SMN1; SMN2CYP1A2KDM4ECYP2D6
SCHEMBL4085836 0.81 HSD17B1 (0.64) HSD17B1SMN1; SMN2CYP1A2KDM4ECYP2D6
SCHEMBL6239769 0.81 KMT2A (0.60) SMN1; SMN2CYP1A2KDM4ECYP2D6CYP2C9
SCHEMBL23512359 0.81 KDM4E (0.49) SRD5A2SMN1; SMN2CYP1A2KDM4ECYP2D6
SCHEMBL8226759 0.81 MAOB (0.49) SRD5A2SMN1; SMN2CYP1A2KDM4ECYP2D6
SCHEMBL21004635 0.80 BACE1 (0.44) SRD5A2SMN1; SMN2CYP1A2KDM4ECYP2D6
SCHEMBL10922062 0.80 CYP2C19 (0.55) HSD17B1SMN1; SMN2CYP1A2KDM4ECYP2D6
SCHEMBL4961133 0.79 PTPN1 (0.50) SMN1; SMN2CYP1A2KDM4ECYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013176-A2 DIARYL COMPOUNDS AS NON-STEROIDAL INHIBITORS OF 17-BETA HYDROXYSTEROID DEHYDROGENASE AND/OR STEROID SULPHATASE FOR THE TREATMENT OF OESTROGEN-RELATED DISEASES SUCH AS HORMONE DEPENDENT BREAST CANCER Sterix Limited (GB) 2009-01-14 EP disclosed
WO-2007096647-A2 DIARYL COMPOUNDS AS NON-STEROIDAL INHIBITORS OF 17-BETA HYDROXYSTEROID DEHYDROGENASE AND/OR STEROID SULPHATASE FOR THE TREATMENT OF OESTROGEN-RELATED DISEASES SUCH AS HORMONE DEPENDENT BREAST CANCER STERIX LIMITED (GB) 2007-08-30 WO disclosed